Brandes Investment Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Brandes Investment Partners's OGN Position: Q2 2026 in Review
Brandes Investment Partners increased its Organon & Co (OGN) stake by 5.5% in Q2 2026, buying an estimated $453K and bringing the position to 729,502 shares worth $9.88M. The position accounts for 0.07% of the portfolio, ranked #131.
Brandes Investment Partners first reported a position in OGN in Q2 2021 and has held it in 13 quarters since. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Brandes Investment Partners held 729,502 shares of Organon & Co worth $9.88M as of Q2 2026.
- Brandes Investment Partners bought 37,877 Organon & Co shares in Q2 2026, an estimated $453K.
- Organon & Co made up 0.07% of Brandes Investment Partners's portfolio in Q2 2026, its #131 holding.
- Brandes Investment Partners first reported a position in Organon & Co in Q2 2021 and has held it in 13 quarters since.
- 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Brandes Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.